Section Arrow
Quote
BCYC.NASDAQ
- Bicycle Therapeutics plc
Quotes are at least 15-min delayed:2024/05/16 07:57 EDT
Last
 22.36
+0.51 (+2.33%)
Day High 
23.09 
Prev. Close
21.85 
1-M High
26.76 
Volume 
386.47K 
Bid
20
Ask
26.89
Day Low
22 
Open
22.1 
1-M Low
21.6101 
Market Cap 
831.90M 
Currency USD 
P/E -- 
%Yield 0 
10-SMA 23.44 
20-SMA 23.21 
50-SMA 23.69 
52-W High 28.91 
52-W Low 12.54 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-4.40/-5.45
Enterprise Value
871.98M
Balance Sheet
Book Value Per Share
9.35
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
26.98M
Operating Revenue Per Share
0.65
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
DNAGinkgo Bioworks Holdings0.8391-0.0237-2.75%-- 
NVAXNovavax12.9-0.58-4.30%-- 
JAGXJaguar Health0.2551-0.0198-7.20%-- 
OCGNOcugen1.96+0.26+15.29%-- 
ARQTArcutis Biotherapeutics9.24+1.11+13.65%-- 
Quotes are at least 15-min delayed：2024/05/16 07:57 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.